ALFA FinderEvery NSE & BSE company
5,879 listed companies, ranked by market cap. Open any company to see every announcement it has filed: order wins, results, earnings calls, fund raises, board meetings and more.
Sector
All sectors
Banking and Finance 634Commercial Services & Supplies 606General Industrials 504Textiles Apparels & Accessories 476Software & Services 322Cement and Construction 266Metals & Mining 264Chemicals & Petrochemicals 262Pharmaceuticals & Biotechnology 235Food, Beverages & Tobacco 233Realty 224Automobiles & Auto Components 218Consumer Durables 188FMCG 142Transportation 139Diversified Consumer Services 131Utilities 118Media 113Healthcare 102Retailing 95Hotels Restaurants & Tourism 89Oil & Gas 45Others 40Fertilizers 31Hardware Technology & Equipment 28Diversified 26Telecommunications Equipment 21Forest Materials 20Telecom Services 20
| # | Company | Sector | Market cap | Announcements | Latest |
|---|---|---|---|---|---|
| 1647 | Remus Pharmaceuticals LtdNSE: REMUS | Pharmaceuticals & Biotechnology | ₹955.6 Cr | 26 | Earnings Call4 Nov 2026 |
| 1660 | Themis Medicare LtdNSE: THEMISMED · BSE: 530199 | Pharmaceuticals & Biotechnology | ₹929.3 Cr | 38 | Other Announcement5 Nov 2026 |
| 1676 | Amanta Healthcare LtdNSE: AMANTA · BSE: 544502 | Pharmaceuticals & Biotechnology | ₹910.4 Cr | 45 | Promoter Buying (Off-Market)7 Nov 2026 |
| 1704 | Aptus Pharma LtdBSE: 544529 | Pharmaceuticals & Biotechnology | ₹852.4 Cr | 31 | Preferential Issue12 Nov 2026 |
| 1716 | Shree Ganesh Remedies LtdNSE: SGRL · BSE: 540737 | Pharmaceuticals & Biotechnology | ₹839.6 Cr | 27 | Earnings Call1 Nov 2026 |
| 1726 | Anuh Pharma LtdNSE: ANUHPHR · BSE: 506260 | Pharmaceuticals & Biotechnology | ₹826.4 Cr | 26 | Promoter Reclassification30 Oct 2026 |
| 1783 | Zim Laboratories LtdNSE: ZIMLAB · BSE: 541400 | Pharmaceuticals & Biotechnology | ₹756.0 Cr | 39 | Earnings Call4 Nov 2026 |
| 1784 | Kilitch Drugs(I) LtdNSE: KILITCH · BSE: 524500 | Pharmaceuticals & Biotechnology | ₹752.1 Cr | 18 | Annual General Meeting12 Nov 2026 |
| 1861 | Wanbury LtdNSE: WANBURY · BSE: 524212 | Pharmaceuticals & Biotechnology | ₹676.5 Cr | 39 | Regulatory Approval12 Nov 2026 |
| 1886 | Influx Healthtech LtdNSE: INFLUX | Pharmaceuticals & Biotechnology | ₹648.8 Cr | 23 | Earnings Call5 Nov 2026 |
| 1969 | Valiant Laboratories LtdNSE: VALIANTLAB · BSE: 543998 | Pharmaceuticals & Biotechnology | ₹570.1 Cr | 28 | Financial Results2 Nov 2026 |
| 2047 | Trident Lifeline LtdNSE: TLL · BSE: 543616 | Pharmaceuticals & Biotechnology | ₹496.7 Cr | 50 | Earnings Call5 Nov 2026 |
| 2071 | Haleos Labs LtdNSE: HALEOSLABS · BSE: 540679 | Pharmaceuticals & Biotechnology | ₹480.8 Cr | 28 | Financial Results11 Nov 2026 |
| 2090 | Ennature Bio Pharma LtdNSE: ENNATURE · BSE: 545012 | Pharmaceuticals & Biotechnology | ₹466.6 Cr | 6 | Management Change12 Nov 2026 |
| 2120 | Albert David LtdNSE: ALBERTDAVD · BSE: 524075 | Pharmaceuticals & Biotechnology | ₹448.0 Cr | 22 | Financial Results12 Nov 2026 |
| 2154 | Jenburkt Pharmaceuticals LtdNSE: JENBURPH · BSE: 524731 | Pharmaceuticals & Biotechnology | ₹424.4 Cr | 21 | Capital Structure Change4 Nov 2026 |
| 2174 | Infinium Pharmachem LtdNSE: INFINIUM | Pharmaceuticals & Biotechnology | ₹411.9 Cr | 20 | Financial Results6 Nov 2026 |
| 2196 | Medicamen Biotech LtdNSE: MEDICAMEQ · BSE: 531146 | Pharmaceuticals & Biotechnology | ₹396.1 Cr | 21 | Financial Results13 Nov 2026 |
| 2246 | Astonea Labs LtdBSE: 544409 | Pharmaceuticals & Biotechnology | ₹367.9 Cr | 27 | Board Meeting Date30 Oct 2026 |
| 2298 | Patel Chem Specialities LtdBSE: 544460 | Pharmaceuticals & Biotechnology | ₹338.2 Cr | 26 | Financial Results5 Nov 2026 |
| 2332 | Aarey Drugs & Pharmaceuticals LtdNSE: AAREYDRUGS · BSE: 524412 | Pharmaceuticals & Biotechnology | ₹326.5 Cr | 19 | Board Meeting Date6 Nov 2026 |
| 2392 | Lyka Labs LtdNSE: LYKALABS · BSE: 500259 | Pharmaceuticals & Biotechnology | ₹302.0 Cr | 30 | Legal & Regulatory2 Nov 2026 |
| 2406 | Ambalal Sarabhai Enterprises LtdNSE: AMBALALSA · BSE: 500009 | Pharmaceuticals & Biotechnology | ₹295.7 Cr | 18 | Financial Results5 Nov 2026 |
| 2527 | Accretion Nutraveda LtdBSE: 544694 | Pharmaceuticals & Biotechnology | ₹252.5 Cr | 19 | Earnings Call3 Nov 2026 |
| 2532 | Sat Kartar Life LtdNSE: SATKARTAR | Pharmaceuticals & Biotechnology | ₹251.0 Cr | 66 | Capacity Expansion12 Nov 2026 |
| 2547 | Everest Organics LtdNSE: EVERESTO · BSE: 524790 | Pharmaceuticals & Biotechnology | ₹244.7 Cr | 16 | Financial Results12 Nov 2026 |
| 2570 | Nectar Lifesciences LtdNSE: NECLIFE · BSE: 532649 | Pharmaceuticals & Biotechnology | ₹239.1 Cr | 27 | Board Meeting Date6 Nov 2026 |
| 2577 | Zenotech Laboratories LtdNSE: ZENOTECH · BSE: 532039 | Pharmaceuticals & Biotechnology | ₹238.1 Cr | 14 | Financial Results28 Oct 2026 |
| 2582 | BDH Industries LtdNSE: BDH · BSE: 524828 | Pharmaceuticals & Biotechnology | ₹237.1 Cr | 19 | Financial Results12 Nov 2026 |
| 2598 | Accretion Pharmaceuticals LtdNSE: ACCPL | Pharmaceuticals & Biotechnology | ₹233.4 Cr | 21 | Earnings Call3 Nov 2026 |
| 2612 | Gennex Laboratories LtdNSE: GENNEX · BSE: 531739 | Pharmaceuticals & Biotechnology | ₹229.8 Cr | 22 | Board Meeting Date3 Nov 2026 |
| 2693 | Sanjivani Paranteral LtdNSE: SANJIVIN · BSE: 531569 | Pharmaceuticals & Biotechnology | ₹210.3 Cr | 29 | Convertible Warrants7 Nov 2026 |
| 2756 | Smruthi Organics LtdNSE: SMRUTHI · BSE: 540686 | Pharmaceuticals & Biotechnology | ₹193.2 Cr | 22 | Financial Results13 Nov 2026 |
| 2763 | Coral Laboratories LtdNSE: CORALAB · BSE: 524506 | Pharmaceuticals & Biotechnology | ₹191.6 Cr | 22 | Board Meeting Date4 Nov 2026 |
| 2775 | Bio Medica Laboratories LtdNSE: BMLL | Pharmaceuticals & Biotechnology | ₹188.6 Cr | 13 | Financial Results13 Nov 2026 |
| 2776 | Brooks Laboratories LtdNSE: BROOKS · BSE: 533543 | Pharmaceuticals & Biotechnology | ₹188.6 Cr | 25 | Credit Rating12 Nov 2026 |
| 2782 | Oxygenta Pharmaceutical LtdNSE: SSORGS · BSE: 524636 | Pharmaceuticals & Biotechnology | ₹187.8 Cr | 14 | Financial Results10 Nov 2026 |
| 2786 | Achyut Healthcare LtdBSE: 543499 | Pharmaceuticals & Biotechnology | ₹186.1 Cr | 26 | Financial Results26 Oct 2026 |
| 2837 | Makers Laboratories LtdNSE: MAKERSL · BSE: 506919 | Pharmaceuticals & Biotechnology | ₹177.4 Cr | 20 | Financial Results4 Nov 2026 |
| 2839 | Kerala Ayurveda LtdNSE: KERALAYUR · BSE: 530163 | Pharmaceuticals & Biotechnology | ₹177.1 Cr | 30 | Results Update12 Nov 2026 |
| 2924 | Natural Capsules LtdNSE: NATCAPSUQ · BSE: 524654 | Pharmaceuticals & Biotechnology | ₹158.4 Cr | 39 | Preferential Issue13 Nov 2026 |
| 2930 | Gujarat Inject (Kerala) LtdBSE: 524238 | Pharmaceuticals & Biotechnology | ₹157.2 Cr | 33 | Financial Results5 Nov 2026 |
| 2949 | Kimia Biosciences LtdNSE: LAURLOR · BSE: 530313 | Pharmaceuticals & Biotechnology | ₹153.8 Cr | 20 | Financial Results13 Nov 2026 |
| 2957 | Medico Remedies LtdNSE: MEDICO · BSE: 540937 | Pharmaceuticals & Biotechnology | ₹153.0 Cr | 21 | Other Announcement9 Nov 2026 |
| 2965 | Syschem (India) LtdNSE: SYSCHEM · BSE: 531173 | Pharmaceuticals & Biotechnology | ₹151.6 Cr | 39 | Management Change13 Nov 2026 |
| 2976 | Himalaya Nutravedics India LtdBSE: 544943 | Pharmaceuticals & Biotechnology | ₹149.6 Cr | 9 | Earnings Call13 Nov 2026 |
| 2979 | Quest Laboratories LtdNSE: QUESTLAB | Pharmaceuticals & Biotechnology | ₹149.1 Cr | 14 | Other Announcement11 Nov 2026 |
| 2983 | Speciality Medicines LtdNSE: SPML · BSE: 544738 | Pharmaceuticals & Biotechnology | ₹148.8 Cr | 16 | Financial Results12 Nov 2026 |
| 3003 | Par Drugs & Chemicals LtdNSE: PAR | Pharmaceuticals & Biotechnology | ₹146.4 Cr | 19 | Financial Results29 Oct 2026 |
| 3005 | Auro Laboratories LtdNSE: AUROLAB · BSE: 530233 | Pharmaceuticals & Biotechnology | ₹146.0 Cr | 18 | Financial Results13 Nov 2026 |
| 3012 | Bal Pharma LtdNSE: BALPHARMA · BSE: 524824 | Pharmaceuticals & Biotechnology | ₹144.8 Cr | 37 | Other Announcement11 Nov 2026 |
| 3024 | Anlon Healthcare LtdNSE: AHCL · BSE: 544497 | Pharmaceuticals & Biotechnology | ₹143.2 Cr | 51 | Earnings Call6 Nov 2026 |
| 3026 | Sotac Pharmaceuticals LtdNSE: SOTAC | Pharmaceuticals & Biotechnology | ₹142.9 Cr | 15 | Financial Results13 Nov 2026 |
| 3041 | Panchsheel Organics LtdNSE: PANCHSHEEL · BSE: 531726 | Pharmaceuticals & Biotechnology | ₹140.5 Cr | 21 | Promoter Buying7 Nov 2026 |
| 3045 | Asston Pharmaceuticals LtdBSE: 544445 | Pharmaceuticals & Biotechnology | ₹140.0 Cr | 29 | Financial Results12 Nov 2026 |
| 3063 | Curis Lifesciences LtdNSE: CURIS | Pharmaceuticals & Biotechnology | ₹137.5 Cr | 22 | Other Announcement11 Nov 2026 |
| 3106 | Lactose (India) LtdNSE: LACTOSE · BSE: 524202 | Pharmaceuticals & Biotechnology | ₹131.4 Cr | 21 | Board Meeting Date6 Nov 2026 |
| 3118 | Balaxi Pharmaceuticals LtdNSE: BALAXI | Pharmaceuticals & Biotechnology | ₹129.4 Cr | 22 | Results Update12 Nov 2026 |
| 3131 | Krebs Biochemicals & Industries LtdNSE: KREBSBIO · BSE: 524518 | Pharmaceuticals & Biotechnology | ₹127.7 Cr | 17 | Financial Results29 Oct 2026 |
| 3157 | Godavari Drugs LtdNSE: GODAVARI · BSE: 530317 | Pharmaceuticals & Biotechnology | ₹123.5 Cr | 19 | Financial Results11 Nov 2026 |
| 3162 | Parnax Lab LtdNSE: PARNAXLAB · BSE: 506128 | Pharmaceuticals & Biotechnology | ₹123.3 Cr | 25 | Financial Results12 Nov 2026 |
| 3203 | Alpa Laboratories LtdNSE: ALPA · BSE: 532878 | Pharmaceuticals & Biotechnology | ₹117.8 Cr | 22 | Board Meeting Date4 Nov 2026 |
| 3296 | Tyche Industries LtdNSE: TYCHE · BSE: 532384 | Pharmaceuticals & Biotechnology | ₹107.0 Cr | 15 | Financial Results13 Nov 2026 |
| 3314 | Veerhealth Care LtdNSE: NIYATILEAS · BSE: 511523 | Pharmaceuticals & Biotechnology | ₹104.8 Cr | 37 | Board Meeting Date30 Oct 2026 |
| 3351 | Pharmaids Pharmaceuticals LtdNSE: PHARMAID · BSE: 524572 | Pharmaceuticals & Biotechnology | ₹100.5 Cr | 17 | Financial Results11 Nov 2026 |
| 3357 | Cian Healthcare LtdNSE: CHCL · BSE: 542678 | Pharmaceuticals & Biotechnology | ₹99.92 Cr | 14 | Board Meeting Date8 Nov 2026 |
| 3399 | Vaishali Pharma LtdNSE: VAISHALI | Pharmaceuticals & Biotechnology | ₹95.44 Cr | 21 | Management Change5 Nov 2026 |
| 3412 | Concord Drugs LtdNSE: CONCORD · BSE: 538965 | Pharmaceuticals & Biotechnology | ₹94.44 Cr | 19 | Financial Results12 Nov 2026 |
| 3425 | Mercury Laboratories LtdNSE: MERCURYLAB · BSE: 538964 | Pharmaceuticals & Biotechnology | ₹93.32 Cr | 27 | Financial Results5 Nov 2026 |
| 3459 | JFL Life Sciences LtdNSE: JFLLIFE | Pharmaceuticals & Biotechnology | ₹88.76 Cr | 15 | ED Probe / Tax Survey3 Nov 2026 |
| 3476 | Amwill Health Care LtdBSE: 544353 | Pharmaceuticals & Biotechnology | ₹86.42 Cr | 21 | Business Update13 Nov 2026 |
| 3480 | Denis Chem Lab LtdNSE: DENISCHEM · BSE: 537536 | Pharmaceuticals & Biotechnology | ₹86.08 Cr | 26 | Capital Structure Change13 Nov 2026 |
| 3532 | Shelter Pharma LtdBSE: 543963 | Pharmaceuticals & Biotechnology | ₹81.46 Cr | 51 | Other Announcement7 Nov 2026 |
| 3540 | Vilin Bio Med LtdNSE: VILINBIO | Pharmaceuticals & Biotechnology | ₹80.67 Cr | 21 | Other Announcement27 Oct 2026 |
| 3545 | Samrat Pharmachem LtdNSE: SAMRATPH · BSE: 530125 | Pharmaceuticals & Biotechnology | ₹80.46 Cr | 16 | Other Announcement13 Oct 2026 |
| 3576 | Source Natural Foods & Herbal Supplements LtdNSE: SOURCENTRL · BSE: 531398 | Pharmaceuticals & Biotechnology | ₹77.60 Cr | 18 | Board Meeting Date7 Nov 2026 |
| 3631 | Vineet Laboratories LtdNSE: VINEETLAB · BSE: 543298 | Pharmaceuticals & Biotechnology | ₹72.56 Cr | 25 | Other Announcement13 Nov 2026 |
| 3635 | Zenith Drugs LtdNSE: ZENITHDRUG | Pharmaceuticals & Biotechnology | ₹72.20 Cr | 27 | Board Meeting Date7 Nov 2026 |
| 3641 | Sunil Healthcare LtdNSE: SUNLOC · BSE: 537253 | Pharmaceuticals & Biotechnology | ₹71.78 Cr | 18 | Financial Results13 Nov 2026 |
| 3654 | Onyx Biotec LtdNSE: ONYX | Pharmaceuticals & Biotechnology | ₹70.90 Cr | 22 | Open Offer11 Nov 2026 |
| 3798 | Genpharmasec LtdNSE: ADIRASA · BSE: 531592 | Pharmaceuticals & Biotechnology | ₹59.80 Cr | 23 | Management Change3 Nov 2026 |
| 3814 | CCME Global LtdNSE: SSK · BSE: 514336 | Pharmaceuticals & Biotechnology | ₹59.08 Cr | 33 | Board Meeting Date9 Nov 2026 |
| 3881 | Phaarmasia LtdNSE: PHRMASI · BSE: 523620 | Pharmaceuticals & Biotechnology | ₹54.10 Cr | 19 | Financial Results12 Nov 2026 |
| 3885 | ANG Lifesciences India LtdNSE: ANG · BSE: 540694 | Pharmaceuticals & Biotechnology | ₹53.76 Cr | 17 | Board Meeting Date6 Nov 2026 |
| 3922 | Biofil Chemicals & Pharmaceuticals LtdNSE: BIOFILCHEM · BSE: 524396 | Pharmaceuticals & Biotechnology | ₹51.08 Cr | 15 | Board Meeting Date3 Nov 2026 |
| 3936 | Parmax Pharma LtdNSE: PARMAX · BSE: 540359 | Pharmaceuticals & Biotechnology | ₹50.51 Cr | 35 | Board Meeting Date10 Nov 2026 |
| 3968 | Kabra Drugs LtdNSE: KABRADG · BSE: 524322 | Pharmaceuticals & Biotechnology | ₹48.93 Cr | 32 | Financial Results6 Nov 2026 |
| 4007 | Rajnish Wellness LtdBSE: 541601 | Pharmaceuticals & Biotechnology | ₹46.71 Cr | 16 | Partnership12 Nov 2026 |
| 4012 | Mangalam Drugs and Organics LtdNSE: MANGALAM · BSE: 532637 | Pharmaceuticals & Biotechnology | ₹46.27 Cr | 41 | Financial Results5 Nov 2026 |
| 4034 | Chandra Bhagat Pharma LtdBSE: 542934 | Pharmaceuticals & Biotechnology | ₹45.27 Cr | 17 | Financial Results13 Nov 2026 |
| 4068 | Rekvina Laboratories LtdNSE: VINRKLB · BSE: 526075 | Pharmaceuticals & Biotechnology | ₹43.78 Cr | 29 | Financial Results13 Nov 2026 |
| 4081 | Vivimed Labs LtdNSE: VIVIMEDLAB · BSE: 532660 | Pharmaceuticals & Biotechnology | ₹43.12 Cr | 14 | Insolvency Petition26 Sep 2026 |
| 4153 | Medicamen Organics LtdNSE: MEDIORG | Pharmaceuticals & Biotechnology | ₹39.07 Cr | 27 | Convertible Warrants7 Nov 2026 |
| 4159 | Vasundhara Rasayans LtdNSE: VRL · BSE: 538634 | Pharmaceuticals & Biotechnology | ₹38.87 Cr | 17 | Financial Results12 Nov 2026 |
| 4160 | Bharat Immunological & Biologicals Corporation LtdNSE: BIBCL · BSE: 524663 | Pharmaceuticals & Biotechnology | ₹38.86 Cr | 1 | Merger & Restructuring17 Sep 2026 |
| 4168 | Vista Pharmaceuticals LtdNSE: VISTAPH · BSE: 524711 | Pharmaceuticals & Biotechnology | ₹38.47 Cr | 9 | Management Change12 Sep 2026 |
| 4224 | Sandu Pharmaceuticals LtdNSE: SANDUPHQ · BSE: 524703 | Pharmaceuticals & Biotechnology | ₹36.23 Cr | 25 | Board Meeting Date4 Nov 2026 |
| 4274 | Roopa Industries LtdNSE: ROOPAIND · BSE: 530991 | Pharmaceuticals & Biotechnology | ₹33.92 Cr | 14 | Board Meeting Date7 Nov 2026 |
| 4310 | Gujarat Terce Laboratories LtdNSE: GUJTERC · BSE: 524314 | Pharmaceuticals & Biotechnology | ₹32.65 Cr | 19 | Acquisition5 Nov 2026 |
| 4350 | Sunrest Lifescience LtdNSE: SUNREST | Pharmaceuticals & Biotechnology | ₹30.90 Cr | 27 | Other Announcement19 Oct 2026 |